Sun Pharma FY26 revenue rises 11.9% to ₹582 billion
Published on: July 7, 2026, 2:56 a.m. | Source: scanx.trade
Sun Pharmaceutical Industries Limited reported consolidated revenues of ₹582 billion for FY26, an increase of 11.9%. EBITDA rose 16.1% to ₹177 billion, and net profit grew 5% to ₹115 billion. The India formulation business grew 14% to ₹193 billion.
